Position in ETON
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,020,388
+$6,978,835 QoQ
Shares Held
249,182
+201.2% QoQ
Ownership
0.872%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 163 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. ETON ranks #14 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
4,217,767 | $146,229,981 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
4,432,350 | $109,080,132 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
773,978 | $85,865,119 | |
| 4 | ALKS |
Alkermes plc.
|
969,954 | $50,825,589 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
270,754 | $45,632,878 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
2,025,356 | $29,347,408 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
1,066,322 | $21,518,377 | |
| 8 | ZTS |
Zoetis Inc.
|
257,470 | $18,501,794 |
All Filings in ETON
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,020,388 | 249,182 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $2,041,553 | 82,721 | Shares | Other | 2026-05-15 | |
| 2024-12-31 | $481,943 | 36,182 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $123,822 | 20,637 | Shares | Other | 2024-11-14 | |
| 2021-12-31 | $395,074 | 92,092 | Shares | Other | 2022-02-14 | |
| 2021-06-30 | $523,057 | 84,912 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||